(Toyota Corolla 2014 ,Nissan Juke Nismo 2013 Dark Knight) The World In Images :::::::: الـعــالــم فـــي صـــور: Sharks' Virus

Thursday, September 29, 2011

Sharks' Virus

Sharks' Virus Killer Could Cure Humans, Study Suggests

Sharks aren't just tough on the outside—a substance in their bodies can stop viruses in their tracks, a new study says. A cholesterol-like compound found in dogfish sharks' tissue has been shown to combat several viruses that cause hard-to-treat human diseases, such as dengue fever and hepatitis, a new study says. Called squalamine, the compound is already in human clinical trials for cancer and eye disorders, and several hundred people have been exposed without major side effects. The new study revealed that squalamine can also disrupt a virus's life cycle and prevent it from replicating in both tissue cultures and live animals. Though there are plenty of drugs to treat bacterial infections, there are few pharmaceuticals that are effective against viruses. Current antiviral drugs are highly specific—each targeting just one strain of a virus—but strains can easily mutate and become resistant to the medication.
"It's a whole new approach to treatment of viral disease," said study leader Michael Zasloff, of the Georgetown University Medical Center. "It's very possible we could cure several diseases we [now] treat as chronic infections."
"Eureka Moment" For for Shark-based Antiviral Drug
Zasloff discovered squalamine in 1993 while searching for antibacterial agents in sharks, which are immune to some diseases, including all viruses. He found that squalamine—which "looked like nothing else that had ever been described or discovered"—inhibits the growth of blood vessels,  suggesting the molecule could potentially stop cancer cells from multiplying. Human research eventually led to Zasloff's "eureka moment," when he realized squalamine can also disable viruses, he said.  Squalamine is a positively charged molecule, so when it enters a cell, the molecule immediately sticks "like Velcro" to the cell's inner membranes, which have negative charges, Zasloff said. By doing so, squalamine "pops off" any positively charged proteins that were attached to the cell membrane—an action that does no harm to the cell, Zasloff noted. When a virus invades a cell, it expects those proteins to be present on the cell membrane. Without them, the virus can't reproduce. "There is no other compound known to science that does this—this is a remarkable property," Zasloff said. It's also one that has apparently served sharks well for hundreds of millions of years—and possibly explains the creatures' evolutionary success.
The shark's "antiviral defenses have been extraordinary," Zasloff said. "It has adapted a very remarkable immune system and stayed with it."
Squalamine Effective Against Human Viruses
In the study, squalamine thwarted infection of the dengue fever virus in human blood vessel cells and of hepatitis B and D in human liver cells—and with little harm to sharks. Shark tissue is no longer required to produce squalamine, which has been synthesized in the laboratory since 1995.
Zasloff and colleagues also discovered that squalamine inhibited yellow fever, eastern equine encephalitis virus, and murine cytomegalovirus in lab animals—in some cases curing the subjects, according to the study, published this week in the journal Proceedings of the National Academy of Sciences. Current squalamine compounds can access only cells that have "chemical portals" to permit its entry, such as those in blood vessels, capillaries, and the liver. But a squalamine-based drug could potentially be tailored to fight a wide variety of viruses in other types of cells, he said. The results "sounds promising" as antiviral drugs, said Todd Rider, a senior staff scientist at the Massachusetts Institute of Technology's Lincoln Laboratory and Division of Comparative Medicine.
"So far the researchers appear to have shown that squalamine is active against six viruses, although they also found that it does have some toxicity and other side effects in certain cell types at doses roughly comparable to those that were required for antiviral efficacy," Rider said by email. "It will be interesting to see what additional viruses squalamine is or is not effective against, and whether the antiviral efficacy can be achieved without toxicity in any type of tissue." Study leader Zasloff said, though, that all substances have some toxicity, and that clinical trials would reveal how safe the drug is for humans.But based on its known safety so far, Zasloff predicts clinical trials for the antiviral will begin in people in about a year.Sharks have been hiding squalamine in their bodies for 700 million years, he added.  "Now it's a gift to us."

مضاد خارق للفيروسات من أسماك القرش: سفراء الموت يحملون في عروقهم ترياق حياة

ما هي الأفكار التي تتوارد إلى ذهنك حين تسمع كلمة “قِرش” أو ترى صورته؟
قد يكون الموت, الخطر أو حتى الخوف!.. لكن أتدري أن سفير الموت والخوف ذاك يحمل في شرايينه ترياق حياة وأمل ؟ نعم هذا ما أعلنه مجموعة من العلماء في مركز جامعة جورج تاون الطبي في أمريكا، حين اكتشفوا أن جسم القرش ينتج مادةً تستطيع محاربة الفيروسات البشرية بقوة وشراسة كالقرش تماماً!!تسمى هذه المادة سكالامين وهي مادة معروفة للمجتمع الطبي بالفعل منذ سنوات، وتستخدم في تجارب علاج السرطان وعدة أمراض أخرى. وقد أثبتت الأبحاث الجديدة أن مادة السكالامين قادرة أيضاً على تدمير دورة حياة الفيروس ومنعه من التكاثر في الخلايا الحية، فنجحت بالفعل في شفاء مئات المرضى دون أي أعراض جانبية , يعود اكتشاف السكالامين للعام 1993 حين اكتشفها د. مايكل زاسلوف قائد فريق البحث، والذي قال حينها أنها أدهشته لأنه لم يرى مثيلاً لخصائها تلك في أي مادة أخرى ,  ومنذ ذلك الحين بدأ تجربة المادة على الحيوانات فوجدها قادرةً على مواجهة الفيروسيات والحد من انتشارها بكفاءة مدهشة خاصةً في أمراض كالتهاب الكبد والحمى الصفراء، ما دفعه لبدء تجربتها على البشر. ولا توجد أي أعراض جانبية ظاهرة حتى الآن على البشر الذين خضعوا لهذه التجارب. فهل نحن أمام طفرة كبيرة في عالم الأدوية؟






No comments:

Post a Comment